TW200642688A - New use of PDE7 inhibitors - Google Patents
New use of PDE7 inhibitorsInfo
- Publication number
- TW200642688A TW200642688A TW095106687A TW95106687A TW200642688A TW 200642688 A TW200642688 A TW 200642688A TW 095106687 A TW095106687 A TW 095106687A TW 95106687 A TW95106687 A TW 95106687A TW 200642688 A TW200642688 A TW 200642688A
- Authority
- TW
- Taiwan
- Prior art keywords
- new use
- pde7 inhibitors
- pde7
- inhibitor
- neuropathic pain
- Prior art date
Links
- 229940123304 Phosphodiesterase 7 inhibitor Drugs 0.000 title 1
- 239000002606 phosphodiesterase VII inhibitor Substances 0.000 title 1
- 102000010984 Type 7 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 3
- 108010037622 Type 7 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 3
- 239000003112 inhibitor Substances 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 208000021722 neuropathic pain Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to the use of a phosphodiesterase 7 (PDE7) inhibitor in the manufacture of a medicament for the treatment of neuropathic pain and to a method of treating neuropathic pain using an inhibitor of PDE7.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0504209A GB0504209D0 (en) | 2005-03-01 | 2005-03-01 | New use of PDE7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200642688A true TW200642688A (en) | 2006-12-16 |
Family
ID=34430434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095106687A TW200642688A (en) | 2005-03-01 | 2006-02-27 | New use of PDE7 inhibitors |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP4512052B2 (en) |
| CN (1) | CN101146539A (en) |
| AR (1) | AR053687A1 (en) |
| GB (1) | GB0504209D0 (en) |
| TW (1) | TW200642688A (en) |
| ZA (1) | ZA200707147B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI826928B (en) * | 2022-02-16 | 2023-12-21 | 翁豐富 | Synthesis of tricyclic and tetracyclic genipin derivatives as anti-inflammation substance and use thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102731512B (en) * | 2011-04-12 | 2015-04-22 | 天津药物研究院 | Preparation method of lurasidone intermediate and lurasidone |
| CN104211638A (en) * | 2014-08-13 | 2014-12-17 | 李增 | Fatty amino substituted graveoline derivative, its preparation and its application as anti-Alzheimer's disease medicine |
| EP4293023A4 (en) * | 2021-04-21 | 2024-12-18 | Changchun Genescience Pharmaceutical Co., Ltd. | FUSED CYCLIC DERIVATIVE CONTAINING IMIDAZOLE, ITS PREPARATION METHOD AND ITS APPLICATION IN MEDICINE |
| WO2024083150A1 (en) * | 2022-10-19 | 2024-04-25 | 长春金赛药业有限责任公司 | Crystal form of nk3r antagonist, and preparation method therefor and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076953A1 (en) * | 2001-03-21 | 2002-10-03 | Warner-Lambert Company Llc | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| EP1400244A1 (en) * | 2002-09-17 | 2004-03-24 | Warner-Lambert Company LLC | New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
-
2005
- 2005-03-01 GB GB0504209A patent/GB0504209D0/en not_active Ceased
-
2006
- 2006-02-16 CN CNA2006800090675A patent/CN101146539A/en active Pending
- 2006-02-27 TW TW095106687A patent/TW200642688A/en unknown
- 2006-02-27 AR ARP060100717 patent/AR053687A1/en not_active Application Discontinuation
- 2006-02-28 JP JP2006053415A patent/JP4512052B2/en not_active Expired - Fee Related
-
2007
- 2007-08-23 ZA ZA200707147A patent/ZA200707147B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI826928B (en) * | 2022-02-16 | 2023-12-21 | 翁豐富 | Synthesis of tricyclic and tetracyclic genipin derivatives as anti-inflammation substance and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101146539A (en) | 2008-03-19 |
| GB0504209D0 (en) | 2005-04-06 |
| AR053687A1 (en) | 2007-05-16 |
| JP4512052B2 (en) | 2010-07-28 |
| ZA200707147B (en) | 2008-11-26 |
| JP2006241159A (en) | 2006-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0607402A2 (en) | use of pde7 inhibitors to treat neuropathic pain | |
| WO2004105757A3 (en) | Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy | |
| MX349787B (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor. | |
| WO2009114725A3 (en) | Mobilization op hematopoietic stem cells using cdc42 inhibitors | |
| TW200510397A (en) | Conjugated complement cascade inhibitors | |
| IL182417A0 (en) | Mitotic kinesin inhibitors and methods of use thereof | |
| EP1651251A4 (en) | Methods for treating diabetes and related disorders using pde10a inhibitors | |
| WO2005102338A8 (en) | Method of treating neuropathic pain using a crth2 receptor antagonist | |
| WO2007026251A3 (en) | Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma | |
| WO2004091540A3 (en) | Methods of treating pain and compositions for use therefor | |
| WO2007120485A3 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
| NO20076186L (en) | Mitotic kinesin inhibitors and methods for their use | |
| AU2003211009A8 (en) | Compositions and methods for treating pain using cyclooxygenase-1 inhibitors | |
| WO2008155390A3 (en) | Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. | |
| WO2007097980A3 (en) | Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy | |
| TW200642688A (en) | New use of PDE7 inhibitors | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| WO2007149543A3 (en) | Scar treatment using protein phosphatase inhibitors | |
| MX2009010757A (en) | Methods of use of gamma inhibitor compounds for the attenuation of pain. | |
| MXPA05010800A (en) | Hydroxamic acids useful in the treatment of hyper-proliferative disorders. | |
| MXPA04011018A (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders. | |
| ZA200710497B (en) | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders | |
| TW200603792A (en) | Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors | |
| WO2008060837A3 (en) | Methods and compositions for the treatment of cancer | |
| WO2005110464A3 (en) | Irx5 inhibition as treatment for hyperproliferative disorders |